Business Insider25d
Promising Clinical Developments and Strong Financial Position Reinforce ‘Buy’ Rating for Perspective Therapeutics
Justin Walsh, an analyst from JonesTrading, reiterated the Buy rating on Perspective Therapeutics (CATX – Research Report). The associated price target remains the same with $21.00. Justin Walsh ...
Windows Central27d
How to move Start menu to left or center in Taskbar on Windows 11
Do you want the Windows 11 Start menu on the left instead of the center position? Here's how to move it. When you purchase through links on our site, we may earn an affiliate commission.
Business Insider27d
Coherus Presents Final Phase 2 Clinical Casdozokitug Combination Data in Patients with Metastatic Hepatocellular Carcinoma at ASCO-GI 2025
Jan. 22, 2025 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (Coherus, NASDAQ: CHRS), today announced final data from its Phase 2 open label clinical trial evaluating casdozokitug (casdozo), a ...